GEN

AI Emboldens the Exploration of Target Space

When Insilico Medicine’s CEO Alex Zhavoronkov, PhD, and his co-authors wrote their 2023 opinion paper on AI-powered target discovery, 1 he was thinking about how often target discovery is ...
EurekAlert!

AI drives new era of target identification and drug design

Disease modeling and target identification are critical and time-consuming portions of the drug discovery process and areas where artificial intelligence (AI) is already making a substantial impact. A ...
Forbes

AI Is Rapidly Transforming Drug Discovery

The biopharmaceutical industry stands on the cusp of a revolution, with artificial intelligence (AI) emerging as a transformative force in drug development. AI's ability to reduce the time and cost of ...
Frontiers

Drug Discovery for Antimicrobial Resistance: From Target Discovery to Combination Design using experimental and AI approaches

Antimicrobial resistance (AMR) is diminishing the effectiveness of existing antibiotics and intensifying the need for discovery pipelines that are both ...
GEN

Drug Discovery Innovation: Target Deconvolution and Tractability Assessment

Zhongyao Ma, PhD, holds a bachelor’s degree in biology from Shanghai Jiao Tong University and a PhD in genetics and developmental biology from the University of Georgia, U.S. His research focused on ...